SCHEMBL721693

SCHEMBL721693

O=C(O)C1C2C=CC(CC2)C1C(=O)OC(=O)C1C2C=CC(CC2)C1C(=O)O

nearest known ligand 0.74

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.74
TDP1 Q9NUW8 4/20 0.74
APEX1 P27695 1/20 0.74
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LMNA P02545 2/20 0.43
KDM4E B2RXH2 2/20 0.41
EGLN1 Q9GZT9 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
MAPT P10636 1/20 0.41
HSD17B10 Q99714 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.34
PPM1B O75688 1/20 0.33
PTPN1 P18031 1/20 0.33
PPP1CC P36873 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6519223 0.92 POLB (0.61) POLBTDP1APEX1ALDH1A1SMN1; SMN2
SCHEMBL4665372 0.87 POLB (0.59) POLBTDP1APEX1ALDH1A1SMN1; SMN2
SCHEMBL27495 0.87 POLB (0.59) POLBTDP1APEX1ALDH1A1SMN1; SMN2
SCHEMBL572756 0.87 POLB (0.59) POLBTDP1APEX1ALDH1A1SMN1; SMN2
SCHEMBL3787744 0.87 POLB (0.59) POLBTDP1APEX1ALDH1A1SMN1; SMN2
SCHEMBL3777075 0.87 POLB (0.59) POLBTDP1APEX1ALDH1A1SMN1; SMN2
SCHEMBL1005886 0.86 POLB (1.00) POLBTDP1APEX1ALDH1A1SMN1; SMN2
SCHEMBL14529762 0.86 POLB (1.00) POLBTDP1APEX1ALDH1A1SMN1; SMN2
SCHEMBL14450705 0.86 POLB (1.00) POLBTDP1APEX1ALDH1A1SMN1; SMN2
SCHEMBL14529591 0.86 POLB (1.00) POLBTDP1APEX1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4506753-A2 PHOTOSENSITIVE COMPOSITION Duksan Neolux Co., Ltd (KR) 2025-02-12 EP claimed
US-20250044690-A1 PHOTOSENSITIVE COMPOSITION Duksan Neolux Co., Ltd. (KR) 2025-02-06 US claimed
EP-3921382-A1 DEGRADABLE URETHANE AND URETHANE-UREA SYSTEMS LANXESS Corporation (US) 2021-12-15 EP claimed
WO-2021071034-A1 CROSSLINKED COPOLYMER, METHOD FOR PREPARING SAME, AND GAS SEPARATION MEMBRANE COMPRISING SAME CROSSLINKED COPOLYMER 인천대학교 산학협력단 2021-04-15 WO claimed
WO-2020163674-A1 DEGRADABLE URETHANE AND URETHANE-UREA SYSTEMS LANXESS SOLUTIONS US INC. (US) 2020-08-13 WO claimed
US-20200040234-A1 CROSS-LINKABLE ADHESIVE COMPOUND TESA SE (DE) 2020-02-06 US claimed
US-20120049106-A1 MALEIMIDE-FUNCTIONAL MONOMERS IN AMORPHOUS FORM DESIGNER MOLECULES, INC. (US) 2012-03-01 US claimed
EP-2307476-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-04-13 EP claimed
US-20100021839-A1 TONER COMPOSITIONS XEROX CORPORATION (US) 2010-01-28 US claimed
WO-2009152068-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2009-12-17 WO claimed
US-20090312470-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2009-12-17 US claimed
US-20080020276-A1 Non-aqueous electrolyte for battery and non-aqueous electrolyte battery comprising the same BRIDGESTONE CORPORATION (JP) 2008-01-24 US claimed
US-6583248-B1 Methacrylate groups; dental cement AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION 2003-06-24 US claimed
US-6180739-B1 CYCLODEXTRINS WITH ACRYLATE AND ANHYDRIDES AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION 2001-01-30 US claimed
US-5929131-A Polymerizable cyclodextrin derivatives AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1999-07-27 US claimed
US-5792821-A Polymerizable cyclodextrin derivatives AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1998-08-11 US claimed
EP-4730479-A2 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME Kyoto University (JP) 2026-04-22 EP disclosed
US-20250246685-A1 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME KYOTO UNIVERSITY (JP) 2025-07-31 US disclosed
EP-0010941-A1 5-Fluorouracil derivatives, preparation thereof and their pharmaceutical compositions FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-05-14 EP disclosed
US-4087587-A GRAFT POLYMER OF HIGH DENSITY POLYETHYLENE AND UNSATURATED FUSED RING CARBOXYLIC ACID ANHYDRIDE CHEMPLEX COMPANY (US) 1978-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312470-A1 Asymmetric Cyclic Diester Compounds DDT, PCNA, AADAC POLB 582/4885TDP1 2109/4885APEX1 364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.